P

Pear Therapeutics Inc
NASDAQ:PEAR

Watchlist Manager
Pear Therapeutics Inc
NASDAQ:PEAR
Watchlist
Price: 0.0077 USD -15.38% Market Closed
Updated: May 19, 2024

Pear Therapeutics Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pear Therapeutics Inc
Gross Profit Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
GDRX

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
P
Pear Therapeutics Inc
NASDAQ:PEAR
Gross Profit
$5.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Gross Profit
$1.7B
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
29%
Inspire Medical Systems Inc
NYSE:INSP
Gross Profit
$559.4m
CAGR 3-Years
70%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Gross Profit
$447.3m
CAGR 3-Years
23%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Gross Profit
$424.8m
CAGR 3-Years
34%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Goodrx Holdings Inc
NASDAQ:GDRX
Gross Profit
$683.3m
CAGR 3-Years
9%
CAGR 5-Years
23%
CAGR 10-Years
N/A

See Also

What is Pear Therapeutics Inc's Gross Profit?
Gross Profit
5.3m USD

Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Gross Profit amounts to 5.3m USD.